Jenny Karlsson

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors
    Jenny Karlsson
    Department of Clinical Genetics, BMC B13, University and Regional Laboratories, Lund University, 221 84 Lund, Sweden
    Virchows Arch 459:547-53. 2011
  2. ncbi SIX1 protein expression selectively identifies blastemal elements in Wilms tumor
    Daniel Sehic
    Department of Clinical Genetics, Lund University, University and Regional Laboratories, Lund, Sweden
    Pediatr Blood Cancer 59:62-8. 2012
  3. ncbi Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia
    Jenny Karlsson
    Department of Laboratory Medicine, Division of Molecular Medicine, Lund University, University Hospital MAS, Malm, Sweden
    Mol Cancer Ther 4:1128-35. 2005
  4. ncbi Arsenic trioxide and neuroblastoma cytotoxicity
    Helen M Pettersson
    Department of Laboratory Medicine, Division of Molecular Medicine, Lund University, University Hospital MAS, Malmo, Sweden
    J Bioenerg Biomembr 39:35-41. 2007
  5. ncbi Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells
    Helen M Pettersson
    Center for Molecular Pathology, CREATE Health, Department of Laboratory Medicine, Lund University, University Hospital MAS, Entrance 78, SE 205 02 Malmo, Sweden
    Mol Cancer Ther 8:160-70. 2009
  6. ncbi Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster
    Linda Holmquist Mengelbier
    Department of Clinical Genetics, University and Regional Laboratories, Lund University, Skane University Hospital, SE 221 85 Lund, Sweden
    Am J Pathol 177:2609-21. 2010
  7. ncbi Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation
    Anders Edsjö
    Department of Laboratory Medicine, Molecular Medicine, Lund University, University Hospital MAS, S 20502 Malmo, Sweden
    Lab Invest 84:406-17. 2004

Collaborators

  • Helen M Pettersson
  • David Gisselsson
  • Daniel Sehic
  • Bengt Sandstedt
  • Linda Holmquist Mengelbier
  • Anders Edsjö
  • Ingrid Øra
  • Margareth Isaksson
  • Attila Frigyesi
  • Johannes Bras
  • Ildiko Frigyesi
  • David Lindgren
  • Sven Påhlman
  • Helen Nilsson
  • Lloyd A Culp
  • Jo Vandesompele
  • Filip Pattyn
  • Frank Speleman

Detail Information

Publications7

  1. ncbi High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors
    Jenny Karlsson
    Department of Clinical Genetics, BMC B13, University and Regional Laboratories, Lund University, 221 84 Lund, Sweden
    Virchows Arch 459:547-53. 2011
    ..Our results indicate that adult WT is a biological entity distinct from the corresponding pediatric tumor type...
  2. ncbi SIX1 protein expression selectively identifies blastemal elements in Wilms tumor
    Daniel Sehic
    Department of Clinical Genetics, Lund University, University and Regional Laboratories, Lund, Sweden
    Pediatr Blood Cancer 59:62-8. 2012
    ..However, there is currently no molecular marker for blastemal cells, and risk stratification for post-nephrectomy treatment is therefore often based on clinico-histological parameters alone...
  3. ncbi Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia
    Jenny Karlsson
    Department of Laboratory Medicine, Division of Molecular Medicine, Lund University, University Hospital MAS, Malm, Sweden
    Mol Cancer Ther 4:1128-35. 2005
    ..Together, our results support As(2)O(3) as a potential candidate drug as a complement to conventional treatments for high-risk neuroblastoma patients and perhaps also for patients with other multidrug-resistant solid tumors...
  4. ncbi Arsenic trioxide and neuroblastoma cytotoxicity
    Helen M Pettersson
    Department of Laboratory Medicine, Division of Molecular Medicine, Lund University, University Hospital MAS, Malmo, Sweden
    J Bioenerg Biomembr 39:35-41. 2007
    ..In this report we discuss the background to the use of arsenic trioxide in cancer therapy and the currently known mechanisms by which arsenic trioxide kills human neuroblastoma cells...
  5. ncbi Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells
    Helen M Pettersson
    Center for Molecular Pathology, CREATE Health, Department of Laboratory Medicine, Lund University, University Hospital MAS, Entrance 78, SE 205 02 Malmo, Sweden
    Mol Cancer Ther 8:160-70. 2009
    ..In addition to cell death induction, antiangiogenic induction of differentiation may also be part of the in vivo effect of As2O3 on SCLC growth, as suggested by an increase in neuroendocrine markers in cultured cells...
  6. ncbi Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster
    Linda Holmquist Mengelbier
    Department of Clinical Genetics, University and Regional Laboratories, Lund University, Skane University Hospital, SE 221 85 Lund, Sweden
    Am J Pathol 177:2609-21. 2010
    ..A disturbed balance between tubular differentiation and self-renewal of anaplastic-blastic elements may thus be one mechanism linking 16q deletion to adverse outcome in Wilms tumor...
  7. ncbi Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation
    Anders Edsjö
    Department of Laboratory Medicine, Molecular Medicine, Lund University, University Hospital MAS, S 20502 Malmo, Sweden
    Lab Invest 84:406-17. 2004
    ....